Page last updated: 2024-11-02

piracetam and Heart Failure

piracetam has been researched along with Heart Failure in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research Excerpts

ExcerptRelevanceReference
"Hyponatremia is frequently seen in heart failure patients and has a high mortality rate."5.42The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia. ( Acaban, MB; Arı, H; Kahraman, F, 2015)
"Hyponatremia is frequently seen in heart failure patients and has a high mortality rate."1.42The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia. ( Acaban, MB; Arı, H; Kahraman, F, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arı, H1
Kahraman, F1
Acaban, MB1

Other Studies

1 other study available for piracetam and Heart Failure

ArticleYear
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2015, Volume: 43, Issue:3

    Topics: Aged; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Epilepsy; Heart Fail

2015